AGTC Announces Positive Three-Month Interim Results From Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, today reported positive three-month interim data from its ongoing Phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa (XLRP).
Cannabix Technologies Correlates THC in Breath and Blood Using Proprietary Sample Collection and Analysis Hardware in Experimental Study
UF startup Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports it has successfully tested a supplemental version of its FAIMS technology for detection of ∆9-tetrahydrocannabinol (“THC”) and related analytes in human breath in an independent experimental study.
BioFlorida Celebration of Biotechnology Shines a Light on the Future of the City of Alachua
BioFlorida held its Celebration of Biotechnology today behind the new AGTC buildings on US Hwy 441 in Alachua, just across from Progress Park, highlighting the future plans for the area that will be known as the Progress District. The Celebration was the first since 2019.
RTI Surgical Is Growing Its Footprint in Progress Park as the Biotech Industry Continues To Develop in Alachua
The biotech industry is expanding in Alachua, and companies are moving to North Central Florida from across the country. Mayor Gib Coerper of the City of Alachua said the growth in the life sciences industry is on a roll across the city.
DHS Announces Cooling Solutions Prize Challenge Finalists in Celebration of Earth Day
UF startup Micro Nano Technologies, announced as finalists in the Cooling Solutions Challenge prize competition. Launched in September 2021, by DHS Science and Technology Directorate (S&T) and the Federal Emergency Management Agency (FEMA), this $195,000 prize competition marks the first in a series focusing on national climate resilience.
SynGatorTron™ To Speed Medical Research, Alleviate Privacy Worries
Medical chatbots that can talk to people using conversational language may be available on your cell phone or computer soon thanks to SynGatorTron™, a groundbreaking artificial intelligence tool developed by UF Health and NVIDIA.
Entrinsic Bioscience Steps Closer to Amino Acid Formulation as Therapy for Cystic Fibrosis
Entrinsic Bioscience and its licensee Nuvara Therapeutics announce they are one step closer to using RxAA formulations as a therapy for patients with Cystic Fibrosis Class I mutations
Entrinsic Bioscience Announces Tool with Potential for Development of New Therapies Addressing Constipation
Entrinsic Bioscience announces a tool to measure intestinal peristalsis that could lead to the development of therapeutic agents for constipation, including Irritable Bowel Syndrome-Constipation (IBS-C).
Oragenics Extends Collaboration To Develop Vaccines Against Future Variants of Coronaviruses
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced it has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) that enables Oragenics to pursue an intranasal vaccine designed to protect against future variants of coronaviruses.
LGC Acquires Rapid Genomics, Bolstering Its Position in the Application of Ngs for High-Throughput Genotyping Market in AgBio
LGC has announced the acquisition of UF startup Rapid Genomics, a provider of mid- to high-density Next-Generation Sequencing (NGS) kits and services for genotyping in the agrigenomics market.
